All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F23%3A00079641" target="_blank" >RIV/00159816:_____/23:00079641 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/23:00133476

  • Result on the web

    <a href="https://link.springer.com/article/10.1007/s11010-023-04706-2" target="_blank" >https://link.springer.com/article/10.1007/s11010-023-04706-2</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s11010-023-04706-2" target="_blank" >10.1007/s11010-023-04706-2</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study

  • Original language description

    The renin angiotensin system is a key regulator of blood pressure homeostasis. Angiotensin type 1 (AT(1)R) and 2 receptors (AT(2)R) have been investigated as targets for cisplatin-induced acute kidney injury; however, their therapeutic potential remains inconclusive. This pilot study aimed to determined the effect that acute cisplatin treatment had on angiotensin II (AngII)-induced contraction in blood vessels and expression profiles of AT(1)R and AT(2)R in mouse arteries and kidneys. Male C57BL/6 mice at 18 week of age (n=8) were treated with vehicle or bolus dose of cisplatin (12.5 mg/kg). Thoracic aorta (TA), adnominal aorta (AA), brachiocephalic arteries (BC), iliac arteries (IL) and kidneys were collected for isometric tension and immunohistochemistry analysis. Cisplatin treatment reduced IL contraction to AngII at all doses (p&lt;0.01, p&lt;0.001, p&lt;0.0001); however, AngII did not induce contraction in TA, AA or BC in either treatment group. Following cisplatin treatment, AT(1)R expression was significantly upregulated in the media of TA (p&lt;0.0001) and AA (p&lt;0.0001), and in the endothelium (p&lt;0.05) media (p&lt;0.0001) and adventitia (p&lt;0.01) of IL. Cisplatin treatment significantly reduced AT(2)R expression in the endothelium (p&lt;0.05) and media (p&lt;0.05) of TA. In renal tubules, both AT(1)R (p&lt;0.01) and AT(2)R (p&lt;0.05) were increased following cisplatin treatment. Herein, we report that cisplatin reduces AngII-mediated contraction in IL and may be explained by an absence of normal counterregulatory expression of AT(1)R and AT(2)R, indicating other factors are involved.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10601 - Cell biology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Molecular and Cellular Biochemistry

  • ISSN

    0300-8177

  • e-ISSN

    1573-4919

  • Volume of the periodical

    478

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    10

  • Pages from-to

    2907-2916

  • UT code for WoS article

    001099394000023

  • EID of the result in the Scopus database